#G42

UAE vaccine trial

UAE hits target of 15,000 volunteers for Covid-19 vaccine phase III trials

The target was achieved in less than a month with individuals from 107 nationalities participating in the programme

Abu Dhabi Group 42 (G42)

Abu Dhabi-based G42 joins Israel Aerospace Industries, Rafael to combat Covid-19

They will jointly leverage their combined knowledge, human and technological assets, to accelerate the delivery of solutions to combat the pandemic

Covid-19 vaccine trials

UAE begins world’s first phase III clinical trial of Covid-19 vaccine

If successful, the vaccine could enter the market by the end of 2020 or early 2021

QuantLase Imaging Lab

UAE develops rapid coronavirus laser testing technology with results available in seconds

The device which is expected to be available in the market over the next few months is developed by QuantLase Imaging Lab and will enable rapid mass-scale testing